Roche
Court rules against EMA disclosure
May 2, 2013Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency
The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …
Roche restructures life science business
April 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts
Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
Cancer drugs boost Roche
April 12, 2013Sales and Marketing Cancer, Q1, Roche
Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …
Roche signs Huntington’s deal
April 10, 2013Research and Development, Sales and Marketing Huntington's, Isis, Roche
Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …
Roche chairman standing down
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer
The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …
Roche bins Galapagos tie-up
March 12, 2013Sales and Marketing COPD, Galapagos, Roche
Roche has ended its three-year old alliance with Belgian drug discovery specialist Galapagos because of a ‘strategic change’. The companies …
Contract research news in brief
March 11, 2013Research and Development Accelovance, BioLamina, Clinstar LLC, Critical Path Services, PRA, PSI CRO, Radiant Development, Roche, Synta
Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …
Perjeta approved in EU
March 7, 2013Sales and Marketing Perjeta, Roche
Roche’s oncology brand Perjeta has been approved in Europe to treat patients with an aggressive form of breast cancer. The …
Roche increases data access
February 27, 2013Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche
Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …
FDA approves Kadcyla
February 25, 2013Herceptin, Roche, T-DM1
Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …
Roche censured for drunken conference antics
February 21, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Roche
The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
FDA offers Alzheimer’s guidance
February 11, 2013Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly
The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …
Facility of the year: 2013 winners announced
February 4, 2013Manufacturing and Production Biogen, MedImmune, Merck, Novartis, Roche
Three US and three European manufacturing plants have been selected as category winners for the annual Facility of the Year …
Roche adds head to corporate executive committee
January 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche
Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …
Perjeta recommended in EU
December 18, 2012Sales and Marketing CHMP, Cancer, Perjeta, Roche
Roche’s breast cancer treatment Perjeta has been given the thumbs up by the CHMP, paving the way for its approval …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
